Authors:
Furst, DE
Clements, PJ
Wong, WK
Mayes, MD
Wigley, F
White, B
Weisman, M
Barr, W
Moreland, L
Martin, R
Medsger, TA
Steen, V
Collier, D
Weinstein, A
Lally, E
Varga, J
Weiner, SR
Andrews, B
Abeles, M
Peter, JB
Seibold, JR
Citation: De. Furst et al., Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial, RHEUMATOLOG, 40(6), 2001, pp. 615-622
Authors:
Pope, JE
Bellamy, N
Seibold, JR
Baron, M
Ellman, M
Carette, S
Smith, CD
Chalmers, IM
Hong, P
O'Hanlon, D
Kaminska, E
Markland, J
Sibley, J
Catoggio, L
Furst, DE
Citation: Je. Pope et al., A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma, ARTH RHEUM, 44(6), 2001, pp. 1351-1358
Authors:
Clements, PJ
Wong, WK
Hurwitz, EL
Furst, DE
Mayes, M
White, B
Wigley, F
Weisman, M
Barr, W
Moreland, L
Medsger, TA
Steen, V
Martin, RW
Collier, D
Weinstein, A
Lally, E
Varga, J
Weiner, SR
Andrews, B
Abeles, M
Seibold, JR
Citation: Pj. Clements et al., The Disability Index of the Health Assessment Questionnaire is a predictorand correlate of outcome in the high-dose versus low-dose penicillamine insystemic sclerosis trial, ARTH RHEUM, 44(3), 2001, pp. 653-661
Authors:
Boruchoff, SE
Sturgill, MG
Grasing, KW
Seibold, JR
McCrea, J
Winchell, GA
Kusma, SE
Deutsch, PJ
Citation: Se. Boruchoff et al., The steady-state disposition of indinavir is not altered by the concomitant administration of clarithromycin, CLIN PHARM, 67(4), 2000, pp. 351-359
Authors:
Clements, PJ
Hurwitz, EL
Wong, WK
Seibold, JR
Mayes, M
White, B
Wigley, F
Weisman, M
Barr, W
Moreland, L
Medsger, TA
Steen, VD
Martin, RW
Collier, D
Weinstein, A
Lally, E
Varga, J
Weiner, SR
Andrews, B
Abeles, M
Furst, DE
Citation: Pj. Clements et al., Skin thickness score as a predictor and correlate of outcome in systemic sclerosis - High-dose versus low-dose penicillamine trial, ARTH RHEUM, 43(11), 2000, pp. 2445-2454
Authors:
Seibold, JR
Korn, JH
Simms, R
Clements, PJ
Moreland, LW
Mayes, MD
Furst, DE
Rothfield, N
Steen, V
Weisman, M
Collier, D
Wigley, FM
Merkel, PA
Csuka, ME
Hsu, V
Rocco, S
Erikson, M
Hannigan, J
Harkonen, WS
Sanders, ME
Citation: Jr. Seibold et al., Recombinant human relaxin in the treatment of scleroderma - A randomized, double-blind, placebo-controlled trial, ANN INT MED, 132(11), 2000, pp. 871
Authors:
Sturgill, MG
Seibold, JR
Boruchoff, SE
Yeh, KC
Haddix, H
Deutsch, P
Citation: Mg. Sturgill et al., Trimethoprim/sulfamethoxazole does not affect the steady-state dispositionof indinavir, J CLIN PHAR, 39(10), 1999, pp. 1077-1084
Authors:
Ehrich, EW
Dallob, A
De Lepeleire, I
Van Hecken, A
Riendeau, D
Yuan, WY
Porras, A
Wittreich, J
Seibold, JR
De Schepper, P
Mehlisch, DR
Gertz, BJ
Citation: Ew. Ehrich et al., Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model, CLIN PHARM, 65(3), 1999, pp. 336-347
Authors:
Clements, PJ
Furst, DE
Wong, WK
Mayes, M
White, B
Wigley, F
Weisman, MH
Barr, W
Moreland, LW
Medsger, TA
Steen, V
Martin, RW
Collier, D
Weinstein, A
Lally, E
Varga, J
Weiner, S
Andrews, B
Abeles, M
Seibold, JR
Citation: Pj. Clements et al., High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis - Analysis of a two-year, double-blind, randomized, controlled clinicaltrial, ARTH RHEUM, 42(6), 1999, pp. 1194-1203